Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 3 study of lacosamide as first add-on therapy for partial-onset seizures
2009-011181-28Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of lacosamide in epilepsy and Focal Onset Epilepsy (2 arms), sponsored by UCB. Primary endpoint: Seizure-free status during first 12 weeks of maintenance. Started Aug 2009; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2009-011181-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011181-28.